Case Series: Acute Hemorrhagic Encephalomyelitis After SARS-CoV-2 Vaccination

Mihai Ancau, Friederike Liesche-Starnecker, Johanna Niederschweiberer, Sandro M. Krieg, Claus Zimmer, Charlotte Lingg, Daniela Kumpfmüller, Benno Ikenberg, Markus Ploner, Bernhard Hemmer, Silke Wunderlich, Mark Mühlau, Benjamin Knier

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung

19 Zitate (Scopus)

Abstract

We present three cases fulfilling diagnostic criteria of hemorrhagic variants of acute disseminated encephalomyelitis (acute hemorrhagic encephalomyelitis, AHEM) occurring within 9 days after the first shot of ChAdOx1 nCoV-19. AHEM was diagnosed using magnetic resonance imaging, cerebrospinal fluid analysis and brain biopsy in one case. The close temporal association with the vaccination, the immune-related nature of the disease as well as the lack of other canonical precipitating factors suggested that AHEM was a vaccine-related adverse effect. We believe that AHEM might reflect a novel COVID-19 vaccine-related adverse event for which physicians should be vigilant and sensitized.

OriginalspracheEnglisch
Aufsatznummer820049
FachzeitschriftFrontiers in Neurology
Jahrgang12
DOIs
PublikationsstatusVeröffentlicht - 2 Feb. 2022

Fingerprint

Untersuchen Sie die Forschungsthemen von „Case Series: Acute Hemorrhagic Encephalomyelitis After SARS-CoV-2 Vaccination“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren